Document is current
Any future updates will be listed below
-
Authors
Williams, Elizabeth E.
Lammert, Craig
Vuppalanchi, Raj
- License Information
-
More Information
Article History
Received: 18 May 2025
Accepted: 4 January 2026
First Online: 12 January 2026
Declarations
: Ethics approval This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The human investigation committee (IRB) of IUPUI approved this study.
: RV: Institutional research is supported by Eli Lilly and Company, Galectin Therapeutics, Takeda, AstraZeneca, Zydus Pharmaceuticals, Gilead Sciences, Kowa Pharmaceuticals, and GlaxoSmithKline. Consultant for Madrigal Pharmaceuticals, Akero Therapeutics, Regeneron, 89 Bio, GSK, Cogent Biosciences, Agios, and Merck in various capacities, including steering committees, data safety monitoring committees, and adjudication committees related to hepatic safety and clinical outcomes.
